Foundry Partners, LLC Coherus Bio Sciences, Inc. Transaction History

Foundry Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$16.56 - $18.94 $975,400 - $1.12 Million	-58,901 Closed	0 $0
Q3 2020 Oct 23, 2020	SELL	$17.41 - $19.89 $11,368 - $12,988	-653 Reduced 1.1%	58,901 $1.08 Million
Q2 2020 Aug 03, 2020	SELL	$14.43 - $19.16 $275,584 - $365,917	-19,098 Reduced 24.28%	59,554 $1.06 Million
Q4 2019 Feb 10, 2020	BUY	$16.33 - $21.37 $99,155 - $129,758	6,072 Added 8.37%	78,652 $1.42 Million
Q3 2019 Oct 23, 2019	BUY	$16.3 - $23.37 $554,200 - $794,580	34,000 Added 88.13%	72,580 $1.47 Million
Q2 2019 Jul 18, 2019	BUY	$13.1 - $22.1 $505,398 - $852,618	38,580 New	38,580 $853,000

135

78M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $108M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.